Merger | JUNIPER PHARMACEUTICALS INC | 17th August 2018

Due to the Merger of JUNIPER PHARMACEUTICALS INC with CATALENT INC, the following treatment will be applied to the following indices.

Solactive US Extended Broad Market Index

• JUNIPER PHARMACEUTICALS INC will be removed from the Index.
• The weight of JUNIPER PHARMACEUTICALS INC based on its last close price will be distributed pro rata to remaining Index constituents.
• Effective Date (open): 08/17/2018.